Found: 16
Select item for more details and to access through your institution.
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 8, p. 753, doi. 10.1111/hepr.14025
- By:
- Publication type:
- Article
2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2022, v. 52, n. 4, p. 352, doi. 10.1111/hepr.13745
- By:
- Publication type:
- Article
aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C.
- Published in:
- Hepatology Research, 2021, v. 51, n. 9, p. 933, doi. 10.1111/hepr.13689
- By:
- Publication type:
- Article
Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project.
- Published in:
- PLoS ONE, 2021, v. 16, n. 8, p. 1, doi. 10.1371/journal.pone.0256711
- By:
- Publication type:
- Article
Acute liver failure with severe steatosis induced by mushroom.
- Published in:
- Liver International, 2020, v. 40, n. 9, p. 2291, doi. 10.1111/liv.14588
- By:
- Publication type:
- Article
Kinetics of serum O‐glycosylated M‐hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 9, p. 731, doi. 10.1111/jvh.13869
- By:
- Publication type:
- Article
Editorial: Has MetALD met the presumption? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 61, doi. 10.1111/apt.18015
- By:
- Publication type:
- Article
Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease.
- Published in:
- JGH Open, 2023, v. 7, n. 8, p. 527, doi. 10.1002/jgh3.12939
- By:
- Publication type:
- Article
Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0249435
- By:
- Publication type:
- Article
Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD.
- Published in:
- Biomedicines, 2022, v. 10, n. 11, p. 2806, doi. 10.3390/biomedicines10112806
- By:
- Publication type:
- Article
Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-23357-9
- By:
- Publication type:
- Article
Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5343, doi. 10.3390/cancers15225343
- By:
- Publication type:
- Article
Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3267, doi. 10.3390/cancers13133267
- By:
- Publication type:
- Article
Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01014-x
- By:
- Publication type:
- Article
Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 6, p. 494, doi. 10.1007/s00535-024-02093-z
- By:
- Publication type:
- Article